You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope

Article metrics

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope

 

Online download statistics by month:

Online download statistics by month: August 2020 to August 2024

AbstractFullPdf
Aug 2020506507118
Sep 202023723994
Oct 2020757538
Nov 2020858548
Dec 2020929334
Jan 202113913938
Feb 202110310348
Mar 2021797945
Apr 2021888837
May 2021545434
Jun 2021404052
Jul 2021555555
Aug 2021575775
Sep 202115615661
Oct 2021444444
Nov 2021525246
Dec 2021333735
Jan 2022354619
Feb 2022687936
Mar 2022778731
Apr 2022667139
May 2022747725
Jun 2022767967
Jul 2022586116
Aug 2022575723
Sep 2022556030
Oct 2022758756
Nov 2022595926
Dec 2022323218
Jan 2023575725
Feb 2023949530
Mar 2023606329
Apr 2023383823
May 2023484816
Jun 2023353622
Jul 2023303130
Aug 2023353512
Sep 2023323216
Oct 2023383911
Nov 2023333411
Dec 2023404011
Jan 2024394024
Feb 2024606031
Mar 2024434346
Apr 2024646537
May 2024464619
Jun 2024545428
Jul 2024313210
Aug 20243535171
Total353936211890